Belladonna/Phenobarbital | RE-PB HYOS ELIXIR [Rebel Distributors Corp] | BioPortfolio

12:15 EST 27th January 2019 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Each 5 mL (teaspoonful) of elixir contains:

Phenobarbital, USP ............................................. 16.2 mg(WARNING: may be habit forming)Hyoscyamine Sulfate, USP .............................. 0.1037 mgAtropine Sulfate, USP ..................................... 0.0194 mgScopolamine Hydrobromide, USP ................... 0.0065 mgAlcohol not more than 23.8%


Artificial Grape Flavor, Ethyl Alcohol, FD and C Blue #1, FD and C Red #40, Glycerin, Purified Water USP, Sodium Saccharin,Sorbitol Solution 70%, and Sucrose.

This drug combination provides peripheral anticholinergic/antispasmodic action and mild sedation.

FDA has classified the following indications as “possibly” effective: For use as adjunctive therapy in the treatment ofirritable bowel syndrome (irritable colon, spastic colon, mucous colitis) and acute enterocolitis. May also be useful asadjunctive therapy in the treatment of duodenal ulcer.IT HAS NOT BEEN SHOWN CONCLUSIVELY WHETHER ANTICHOLINERGIC/ ANTISPASMODIC DRUGS AID IN THEHEALING OF A DUODENAL ULCER, DECREASE THE RATE OF RECURRENCES OR PREVENT COMPLICATIONS.

RE-PB Hyos Elixir is contraindicated in patients with known hypersensitivity to any of the ingredients. Phenobarbital iscontraindicated in patients with acute intermittent porphyria and in those patients in which phenobarbital producesrestlessness and/or excitement.

It is also contraindicated in patients with glaucoma, obstructive uropathy; paralytic ileus; myasthenia gravis;intestinal atony; unstable cardiovascular status in acute hemorrhage; hiatal hernia associated with reflux esophagitis;obstructive disease of the gastrointestinal tract; or severe ulcerative colitis

Heat prostration can occur with belladonna alkaloids in high temperatures.

Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy.In this instance, treatment with this drug could be harmful.

RE-PB Hyos Elixir may produce drowsiness and blurred vision. The patient should be warned about engaging in hazardous work or activities requiring mental alertness, such as operating a motor vehicle or other machinery. Phenobarbital may decrease the effect of anticoagulants, and larger doses of the anticoagulant may be needed for optimal effect. When phenobarbital is discontinued, the dose of the anticoagulant may have to be decreased. Phenobarbital may be habit forming and should not be administered to patients who are susceptible to addiction or to those with a history of physical and/or psychological drug dependence.

Barbiturates should be used with caution in patients with hepatic dysfunction.

GENERAL:Use with caution in patients with: autonomic neuropathy, hepatic or renal disease, hyperthyroidism, coronary heartdisease, congestive heart failure, cardiac arrhythmias, tachycardia, and hypertension.

Belladonna alkaloids may produce a delay in gastric emptying (antral stasis) which would complicate the management ofgastric ulcer. Do not rely on the use of the drug in the presence of complication of biliary tract disease. Theoretically,with overdosage, a curare-like action may occur.

CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY CATEGORY C:Animal reproduction studies have not been conducted with RE-PB Hyos Elixir. It is not known whether RE-PB Hyos Elixircan cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. RE-PB Hyos Elixirshould be given to a pregnant woman only if clearly needed.

NURSING MOTHERS:It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, cautionshould be exercised when RE-PB Hyos Elixir is administered to a nursing woman.

Adverse reactions associated with anticholinergics and/or anticonvulsants are: dry mouth; tachycardia; urinaryhesitancy and retention; palpitation; blurred vision; prolonged pupil dilation; cycloplegia; increased ocular tension; loss oftaste sense; headache; nervousness; drowsiness; weakness; dizziness; insomnia; nausea; vomiting; severe allergicreaction or drug idiosyncrasies, including anaphylaxis, hives and/or other dermal manifestations; decreased sweating; impotence; suppression of lactation; constipation; bloated feeling and musculoskeletal pain. Elderly patients may reactwith symptoms of excitement, agitation and drowsiness to even small doses of the drug. Phenobarbital may produceexcitement in some patients, rather than a sedative effect. In patients habituated to barbiturates, abrupt withdrawal mayproduce delirium or convulsions.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

The signs and symptoms of overdose are headache, nausea, vomiting, blurred vision, dilated pupils, hot and

dry skin, dizziness, dryness of the mouth, difficulty in swallowing, and CNS stimulation. Call your doctor or

local Poison Control Center if overdosage is suspected.

The dosage of RE-PB Hyos Elixir should be adjusted to the needs of the individual patient to assuresymptomatic control with a minimum of adverse effects.

Adults: One or two teaspoonfuls of elixir three or four times a day according to conditions and severity of symptoms.

Pediatric patients: may be dosed every 4 to 6 hours.

Starting Dosage

Body Weight
q4h q6h
10 lb. (4.5 kg)
0.5 mL
0.75 mL
20 lb. (9.1 kg)
1.0 mL
1.5 mL
30 lb. (13.6 kg)
1.5 mL
2.0 mL
50 lb. (22.7 kg)
1/2 tsp
3/4 tsp
75 lb. (34 kg)
3/4 tsp
1 tsp
100 lb. (45.4kg)
1 tsp
1 1/2 tsp

RE-PB Hyos Elixir is a purple colored, grape flavored liquid.

NDC 21695-594-16 in bottles of 16 oz.


Manufactured by:Great Southern Laboratories Houston, TX  77099-3405

Manufactured for:River’s Edge Pharmaceuticals, LLCSuwanee, GA 30024

Repackaged by:  Rebel Distributors Corp

Thousand Oaks, CA 91320


Rebel Distributors Corp

Active Ingredients


Drugs and Medications [49 Associated Drugs and Medications listed on BioPortfolio]

Donnatal [pbm pharmaceuticals inc.]

Donnatal Elixir Mint 16 oz

Donnatal [pbm pharmaceuticals inc.]

Donnatal Elixir Mint 4 oz

Donnatal [pbm pharmaceuticals inc.]

Donnatal Elixir 4oz grape flavor

Phenobarbital with belladonna alkaloids [lazarus pharmaceuticals, inc.]


Donnatal [pbm pharmaceuticals inc.]

DONNATAL ELIXIR grape flavor 1 pint

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study With a Single-Arm Registry "EXCELLA II STUDY"

Randomized Study To evaluate the safety and effectiveness of the Elixir Medical Novolimus-Eluting Coronary Stent System with Durable Polymer through the assessment of clinical, angiographi...

Efficacy and Safety of Ginseng Extract on Improvement of Bone Metabolism in Menopausal Women

Recently, osteoprosis has been recognized as a serious health problem in the elderly, it has also increased in young • middle-aged layer. Ginseng is history 2, 000 years Korean typical h...

A Phase I Randomized Dose/Formulation Comparison Study of SC-52151

PRIMARY: To evaluate the safety, tolerability, pharmacokinetics, and ethanol exposure of two dose regimens and formulations of SC-52151. SECONDARY: To evaluate the preliminary anti-HIV ac...

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

The Trademarked Red "Elixir of Life," Hall's Coca Wine.

The elixir phase of chain molecules.

A phase of matter is a familiar notion for inanimate physical matter. The nature of a phase of matter transcends the microscopic material properties. For example, materials in the liquid phase have ce...

Effects of Sagacious Confucius' Pillow Elixir on cognitive function in type 2 diabetic rats.

Type 2 diabetes mellitus (T2DM) is the leading threat to human health in China, and severe cognitive impairment often occurs in most T2DM patients. Although Sagacious Confucius' Pillow Elixir is a typ...

BRENDA in 2019: a European ELIXIR core data resource.

The BRENDA enzyme database (, recently appointed ELIXIR Core Data Resource, is the main enzyme and enzyme-ligand information system. The core database provides a comprehensive o...

Intermittent hypoxia: friend AND foe ExActa.

We are not sure whether Andrew Scott and Trevor Griffin reflected on the phenomenon of intermittent hypoxia, when they wrote this song text in the late seventies - presumably not. These lines may also...

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Drugs and Medication Quicklinks

Searches Linking to this Drug Record